Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
To study the safety and efficacy of anti-CD20 blockade with ofatumumab in the context of
allogeneic HCT in CLL
Phase:
Phase 2
Details
Lead Sponsor:
Technische Universität Dresden
Collaborators:
University Hospital Dresden University Hospital of Cologne University Hospital Schleswig-Holstein University Hospital Ulm University of Schleswig-Holstein